Cargando…
Metformin suppresses SARS-CoV-2 in cell culture
Comorbidities such as diabetes worsen COVID-19 severity and recovery. Metformin, a first-line medication for type 2 diabetes, has antiviral properties and certain studies have also indicated its prognostic potential in COVID-19. Here, we report that metformin significantly inhibits SARS-CoV-2 growth...
Autores principales: | Parthasarathy, Haripriya, Tandel, Dixit, Siddiqui, Abdul Hamid, Harshan, Krishnan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676078/ https://www.ncbi.nlm.nih.gov/pubmed/36417940 http://dx.doi.org/10.1016/j.virusres.2022.199010 |
Ejemplares similares
-
Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential
por: Gupta, Divya, et al.
Publicado: (2021) -
Equine immunoglobulin fragment F(ab’)(2) displays high neutralizing capability against multiple SARS-CoV-2 variants
por: Gupta, Divya, et al.
Publicado: (2022) -
SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells
por: Tandel, Dixit, et al.
Publicado: (2022) -
Detection of SARS-CoV-2 in the air in Indian hospitals and houses of COVID-19 patients
por: Moharir, Shivranjani C., et al.
Publicado: (2022) -
Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma
por: Parveen, Sana, et al.
Publicado: (2017)